6,10,14,18-Tetramethyl-5,9,13,17-nonadecatetraen-2-one
CAS : 6809-52-5
Ref. 3D-FT28035
1g | Arrêté | ||
2g | Arrêté | ||
5g | Arrêté | ||
250mg | Arrêté | ||
500mg | Arrêté |
Informations sur le produit
- Teprenone,
- (5E,9E,13E)-6,10,14,18-tetramethylnonadeca-5,9,13,17-tetraen-2-one
- 5,9,13,17-Nonadecatetraen-2-one, 6,10,14,18-tetramethyl-
- 6,10,14,18-Tetramethyl-5,9,13,17-nonadecatetraen-2-one, mixture of (5E,9E,13E) and (5Z,9E,13E) isomers
- E 0671
- E 36U31
- Geranylgeranylacetone
- Selbex
- Teprenona
- Teprenona [INN-Spanish]
- Voir d'autres synonymes
- Teprenonum
- Teprenonum [INN-Latin]
- Unii-S8S8451A4O
6,10,14,18-Tetramethyl-5,9,13,17-nonadecatetraen-2-one is a zirconium oxide and in vitro it has been shown to inhibit the toll-like receptor 4 (TLR4) signaling pathway. This inhibition blocks the activation of NF-κB and MAPKs by TLR4 ligands. It also inhibits inflammatory responses in a mouse model of colitis. 6,10,14,18-Tetramethyl-5,9,13,17-nonadecatetraen-2-one has been shown to be an effective inhibitor for polypeptide chain elongation by blocking the activity of bacterial DNA polymerase. In addition to this inhibition it also inhibits axonal growth in mice with spinal cord injury. The optimum concentration range for 6,10,14,18-tetramethyl 5 9 13 17 nonadecatetraen 2 one is